Successful Salvage Therapy of Irinotecan for Relapsed Hodgkin's Lymphoma

Kazuhisa URUSHIHATA, Tomonobu KOIZUMI, Toshimichi KANEKI, Shinji YAMAGUCHI, Keisaku FUJIMOTO, Keishi KUBO
2002 Internal medicine (Tokyo. 1992)  
A 30-year-old man, whohad a repeated history of relapsed Hodgkin's lymphoma over 7 years, developed bilateral pleural effusion and chest wall involvement. He was treated with weekly irinotecan hydrochloride (CPT-ll ; 80 mg/m2/week). Partial response was observed after two cycles of irinotecan. Neutropenia and diarrhea were tolerable. This case demonstrated that irinotecan has a therapeutic effect in patients with relapsed Hodgkin's lymphoma. (Internal Medicine 41 : 648-650, 2002)
doi:10.2169/internalmedicine.41.648 fatcat:5pmoijlvpbgvvou3qv3vmlj7pe